CanSino to commence Phase III trial of Covid-19 vaccine in Saudi Arabia
China-based CanSino Biologics is likely to soon commence Phase III clinical trial of its potential Covid-19 vaccine, Ad5-nCOV, in Saudi Arabia. The vaccine has been manufactured using a harmless cold…